Back to Search
Start Over
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG study
- Source :
- Blood Advances; November 2024, Vol. 8 Issue: 21 p5674-5682, 9p
- Publication Year :
- 2024
-
Abstract
- •Ibrutinib–R-mini-CHOP was a deliverable combination in patients with DLBCL aged ≥75 years.•Ibrutinib–R-mini-CHOP improves PFS compared with historical rates reported for R-mini-CHOP, but this study did not demonstrate a superior OS.
Details
- Language :
- English
- ISSN :
- 24739529 and 24739537
- Volume :
- 8
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Blood Advances
- Publication Type :
- Periodical
- Accession number :
- ejs67336244
- Full Text :
- https://doi.org/10.1182/bloodadvances.2024014035